Last reviewed · How we verify
Equol
At a glance
| Generic name | Equol |
|---|---|
| Also known as | Equelle |
| Sponsor | University of Colorado, Denver |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition (PHASE2)
- Acute Equol Supplementation and Vascular Function in Women With and Without CKD (PHASE2)
- Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers (PHASE2)
- Equol and Vascular Function in Women With Chronic Kidney Disease (PHASE2)
- Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause). (NA)
- Study of the Effects of Soy Exposure in Early Life on Bone Development and Gut Microbiota
- A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore
- Open-labelled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |